Malaysia's Medical Tourism Revenue Reopens a Specialist-Drain Debate

Malaysia’s medical tourism generated RM3.3bn in direct medical revenue last year and contributed to roughly RM13bn in total economic activity, Aliran reported. The figures have reopened a domestic argument over who benefits from that revenue, and at what cost to the public hospitals that train the country’s doctors.

The socialist party PSM has argued that the growth of medical tourism, by catering to foreign patients, risks diverting specialist doctors away from Malaysia’s public hospitals. That argument runs against the more familiar case for medical tourism, which rests on the revenue and the jobs it brings in. Aliran, a Malaysian civil-society website, framed the question as one of distribution rather than headline growth, and gave the workforce objection most of its space.

Where the doctors go

The Malaysian Medical Association put a different reading on the same shortage. Its president, Dr R Thirunavukarasu, attributed the departure of doctors from the public sector mainly to problems inside that sector rather than to medical tourism. He cited limited career progression, a lack of transparency in promotions, and unsustainable workloads as the factors driving specialists out. On that reading the remedy is to repair the public system, the article said, rather than to restrict where doctors are allowed to work.

The Malaysian Medical Association’s account and PSM’s account point in different directions from the same fact. Doctors are leaving public hospitals. Whether medical tourism pulls them out, or a strained public system pushes them, is the point in dispute, and the source settles it with argument rather than with figures.

A question of who healthcare is for

The Association for Welfare, Community and Dialogue took the argument further. The organisation argued that the problems in Malaysian healthcare run beyond structural faults to philosophical ones, and that care should be judged from the position of ordinary patients rather than that of providers. It argued that healthcare is a common good and a fundamental human right, and that adequate care should not depend on a patient’s ability to pay. When access to the best care tracks the ability to pay, the organisation warned, the incentive shifts toward treating medicine as a business rather than as healing.

That framing sets the moral terms of the debate, but it does not supply the operational numbers the debate needs. The organisation dealt in principle. PSM dealt in a specific claim about specialist movement. Neither produced a count of doctors who crossed from public wards to private ones.

The multiplier and its limits

Behind the RM13bn total sits a multiplier. Every ringgit spent on medical care generates around RM4 across the wider economy, Aliran reported, spread through hotels, airlines, restaurants, ground transport and retail. On that arithmetic the RM3.3bn in direct medical revenue last year produced the roughly RM13bn in total economic activity that the figures now cite. It is the same hospitality multiplier that has Malaysian hoteliers preparing for the growth ahead of Visit Malaysia 2026.

PSM’s question is where that money lands. PSM asked whether public hospitals had seen any of it, given the movement of doctors toward the private hospitals that serve foreign patients. Official statements have stayed on the revenue side of the ledger; the finance minister has said medical tourism demand stays strong despite a new consumer tax, without addressing the workforce question PSM raised.

A symptom, and the strategy under it

Medical tourism revenue is easy to count and hard to place. The RM3.3bn in direct medical revenue is a real figure, recorded at the point of sale, and the RM4-per-ringgit multiplier is a standard tourism calculation. Neither number shows how much of the gain reaches the public hospitals, or how many specialists moved from public wards to private ones to earn it. That gap is the whole of the dispute.

A specialist drain is a symptom, and the strategy question under it is whether a country plans its medical workforce across the public and private systems at once, or lets the higher-paying side recruit from the lower-paying one. Malaysia’s public hospitals train the specialists, and its private hospitals bill the foreign patients, and the source offers no figure for how many doctors crossed between them. The specialist-drain claim is politically potent and, on the evidence supplied, factually unproven.

Aliran concluded that structural reform in Malaysian healthcare is necessary but must rest on human dignity and social justice, rather than on revenue alone. The test of that is a set of numbers Malaysia has not published: how many public-sector specialists move into private medical tourism work each year, which specialities lose the most, and how much of the RM3.3bn is reinvested in public hospitals or in workforce training. Until those figures appear, the RM13bn total will keep being cited without a public ledger of who received it.